Home
About Us
Management
Thrust Areas
Disclaimer
Dr Boominathan’s Quotes
Ideas
Bio-Med Ideas
Ideas for Free
Bio-Pharma/Med Ideas
Audience Profile
Bio-Medical Ideas-7,900+
Bio-Med Res Grants Aid
p63 and p73 Community
How p63/p73/p53 Field Progresses
Noble Laureate’s work tracked by GBMD
Ideas were viewed by World’s Best 10 Universities
Submit your Ideas
miRNA Therapeutics
Intellectual Property Development
Licensing Opportunities
Partnerships
Investor opportunities
Educational Tools
Scientific Resources
Research
Research Focus
Research Themes
Research – II
Dr Boomi’s Contributions (Res)
Dr Boomi’s caliber (Sci)
Conference publications
Research Publications
Research Training
Ph.D/M.D/M.Tech Mentor
What Scientists Saying
Peer/Manuscript Review
Press/Media Release
Conferences/Meetings
B-MERIIT
Introduction
Founder
What We Assure
M.S program
M.S in Molecular Cancer Biology
M.S in Stem cell Biology & Regenerative Medicine
M.S in Mol. Medicine
M.S in Genome Biology
M.S in Bio-Medical Sciences
Model Building & Model Laboratory
Investor opportunities
Logo
Career guidance
Admission Details
Registration
Terms and conditions
Career/Opportunities
Contact Us
Therapeutic targeting of Self-renewal in human intestinal cancer: Tumor suppressor p53/TA-p73/p63 inhibits the ability of intestinal cancer-initiating cells (CICs) to self renew via up regulation of its target genes, 5/November/2013, 7.04 am
Targeting viral replication with a small molecule compound: Sulfuretin suppresses porcine reproductive and respiratory syndrome virus infection via up regulation of its target gene, 4/November/2013, 9.23 am
December 4, 2013
Targeting Self-renewal in human intestinal cancer with Vitamin A: ATRA inhibits the ability of intestinal cancer-initiating cells (CICs) to self renew via up regulation of its target genes, 5/November/2013, 7.18 am
December 5, 2013
0
Published by
admin_auro
at
December 5, 2013
Categories
Uncategorized
Tags
admin_auro
Comments are closed.
